髓系白血病
魔术(望远镜)
残余物
微小残留病
疾病
医学
人工智能
计算生物学
计算机科学
癌症研究
肿瘤科
白血病
免疫学
内科学
生物
物理
算法
量子力学
作者
Kevin E. Shopsowitz,Jack Lofroth,Geoffrey Chan,Jubin Kim,Manoj Kumar Rana,Ryan R. Brinkman,Andrew P. Weng,N N Medvedev,Xuehai Wang
摘要
Abstract Multiparameter flow cytometry is widely used for acute myeloid leukemia minimal residual disease testing (AML MRD) but is time consuming and demands substantial expertise. Machine learning offers potential advancements in accuracy and efficiency, but has yet to be widely adopted for this application. To explore this, we trained single cell XGBoost classifiers from 98 diagnostic AML cell populations and 30 MRD negative samples. Performance was assessed by cross‐validation. Predictions were integrated with UMAP as a heatmap parameter for an augmented/interactive AML MRD analysis framework, which was benchmarked against traditional MRD analysis for 25 test cases. The results showed that XGBoost achieved a median AUC of 0.97, effectively distinguishing diverse AML cell populations from normal cells. When integrated with UMAP, the classifiers highlighted MRD populations against the background of normal events. Our pipeline, MAGIC‐DR, incorporated classifier predictions and UMAP into flow cytometry standard (FCS) files. This enabled a human‐in‐the‐loop machine learning guided MRD workflow. Validation against conventional analysis for 25 MRD samples showed 100% concordance in myeloid blast detection, with MAGIC‐DR also identifying several immature monocytic populations not readily found by conventional analysis. In conclusion, Integrating a supervised classifier with unsupervised dimension reduction offers a robust method for AML MRD analysis that can be seamlessly integrated into conventional workflows. Our approach can support and augment human analysis by highlighting abnormal populations that can be gated on for quantification and further assessment. This has the potential to speed up MRD analysis, and potentially improve detection sensitivity for certain AML immunophenotypes.
科研通智能强力驱动
Strongly Powered by AbleSci AI